High-dose ranibizumab monotherapy for neovascular polypoidal choroidal vasculopathy in a predominantly non-Asian population

PURPOSE: To determine safety and efficacy of intravitreal high-dose ranibizumab in the treatment of active neovascular polypoidal choroidal vasculopathy (PCV). METHODS: In this Phase I/II, single-center, randomized, controlled, double-masked study, predominantly non-Asian, previously treated or trea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eye (Lond)
Main Authors: Marcus, D M, Singh, H, Fechter, C M, Chamberlain, D P
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2015
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4815656/
https://ncbi.nlm.nih.gov/pubmed/26337944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2015.150
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados